PubRank

Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma

Clinical Trial ID NCT01952769

PubWeight™ 20.30‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01952769

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Concise Guide to PHARMACOLOGY 2015/16: Overview. Br J Pharmacol 2015 2.13
2 Prospects of immune checkpoint modulators in the treatment of glioblastoma. Nat Rev Neurol 2015 1.50
3 Intratumoral immunization: a new paradigm for cancer therapy. Clin Cancer Res 2014 1.24
4 Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy. Oncoimmunology 2014 1.22
5 Immune modulation for cancer therapy. Br J Cancer 2014 1.15
6 Immunotherapy advances for glioblastoma. Neuro Oncol 2014 1.07
7 Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology 2015 1.06
8 Immunotherapy for brain cancer: recent progress and future promise. Clin Cancer Res 2014 0.99
9 Cancer immunotherapy in clinical practice -- the past, present, and future. Chin J Cancer 2014 0.98
10 Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications. Front Immunol 2015 0.92
11 The future of glioblastoma therapy: synergism of standard of care and immunotherapy. Cancers (Basel) 2014 0.91
12 Overview of current immunotherapeutic strategies for glioma. Immunotherapy 2015 0.89
13 The role of IDO in brain tumor immunotherapy. J Neurooncol 2014 0.86
14 Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment. Oncology (Williston Park) 2015 0.85
15 Targeting CD8+ T-cell tolerance for cancer immunotherapy. Immunotherapy 2014 0.81
16 The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment. Oncologist 2015 0.81
17 Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme. Front Oncol 2014 0.79
18 Emerging immunotherapies for glioblastoma. Expert Opin Emerg Drugs 2016 0.77
19 Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium. J Immunol Res 2016 0.77
20 The role of checkpoints in the treatment of GBM. J Neurooncol 2015 0.75
21 Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities. J Pediatr Hematol Oncol 2016 0.75
Next 100